New agents for the treatment of ovarian cancer: The next generation Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms

abstract

  • Ovarian cancer shares many important characteristics with more common malignancies including breast, lung, and colon cancer. The relative chemosensitivity of ovarian cancer and other aspects of its unique biology provide opportunities for novel interventions. In this brief summary, some of the potential targets in ovarian cancer are discussed, including the HER kinases, heat shock protein, the 26S proteasome, and the angiogenesis pathway. The opportunities to change the treatment of ovarian cancer will require creative clinical trial design but the next decade promises to be filled the therapeutic advances for patients with ovarian cancer.

publication date

  • November 2005

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1525-1438.2005.00443.x

PubMed ID

  • 16343241

Additional Document Info

start page

  • 252

end page

  • 7

volume

  • 15

number

  • 6 SUPPL. 3